Titre : Oxygénation hyperbare

Oxygénation hyperbare : Questions médicales fréquentes

Termes MeSH sélectionnés :

REM Sleep Behavior Disorder
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Oxygénation hyperbare : Questions médicales les plus fréquentes", "headline": "Oxygénation hyperbare : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Oxygénation hyperbare : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-26", "dateModified": "2025-04-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Oxygénation hyperbare" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxygénothérapie", "url": "https://questionsmedicales.fr/mesh/D010102", "about": { "@type": "MedicalCondition", "name": "Oxygénothérapie", "code": { "@type": "MedicalCode", "code": "D010102", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.880.690" } } }, "about": { "@type": "MedicalCondition", "name": "Oxygénation hyperbare", "alternateName": "Hyperbaric Oxygenation", "code": { "@type": "MedicalCode", "code": "D006931", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Richard E Moon", "url": "https://questionsmedicales.fr/author/Richard%20E%20Moon", "affiliation": { "@type": "Organization", "name": "Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S." } }, { "@type": "Person", "name": "John P Kirby", "url": "https://questionsmedicales.fr/author/John%20P%20Kirby", "affiliation": { "@type": "Organization", "name": "John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri." } }, { "@type": "Person", "name": "Stephen R Thom", "url": "https://questionsmedicales.fr/author/Stephen%20R%20Thom", "affiliation": { "@type": "Organization", "name": "Emergency Medicine, University of Maryland, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Michael H Bennett", "url": "https://questionsmedicales.fr/author/Michael%20H%20Bennett", "affiliation": { "@type": "Organization", "name": "Department of Diving and Hyperbaric Medicine, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales, Australia." } }, { "@type": "Person", "name": "Simon J Mitchell", "url": "https://questionsmedicales.fr/author/Simon%20J%20Mitchell", "affiliation": { "@type": "Organization", "name": "Department of Anaesthesiology, University of Auckland Faculty of Medicine, Auckland, New Zealand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.", "datePublished": "2023-03-08", "url": "https://questionsmedicales.fr/article/37032242", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neurobiolaging.2023.03.002" } }, { "@type": "ScholarlyArticle", "name": "Free-Water Imaging of the Nucleus Basalis of Meynert in Patients With Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.", "datePublished": "2024-03-15", "url": "https://questionsmedicales.fr/article/38489578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1212/WNL.0000000000209220" } }, { "@type": "ScholarlyArticle", "name": "Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35605512", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.parkreldis.2022.05.010" } }, { "@type": "ScholarlyArticle", "name": "Sleep and wakefulness disturbances in Parkinson's disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia.", "datePublished": "2023-01-16", "url": "https://questionsmedicales.fr/article/36708642", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.smrv.2023.101759" } }, { "@type": "ScholarlyArticle", "name": "Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder.", "datePublished": "2022-12-06", "url": "https://questionsmedicales.fr/article/36474090", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00702-022-02565-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Thérapie respiratoire", "item": "https://questionsmedicales.fr/mesh/D012138" }, { "@type": "ListItem", "position": 4, "name": "Oxygénothérapie", "item": "https://questionsmedicales.fr/mesh/D010102" }, { "@type": "ListItem", "position": 5, "name": "Oxygénation hyperbare", "item": "https://questionsmedicales.fr/mesh/D006931" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Oxygénation hyperbare - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Oxygénation hyperbare", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Oxygénation hyperbare", "description": "Comment diagnostiquer une décompression ?\nQuels tests pour l'oxygénation hyperbare ?\nQuels symptômes indiquent un traitement ?\nComment évaluer l'efficacité du traitement ?\nQuels critères pour l'admission en chambre hyperbare ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Oxygénation hyperbare", "description": "Quels sont les symptômes de l'oxygénation hyperbare ?\nComment se manifeste l'intoxication à l'oxygène ?\nQuels signes d'une embolie gazeuse ?\nQuels symptômes après une séance d'oxygénation ?\nComment reconnaître une réaction allergique ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Oxygénation hyperbare", "description": "Comment prévenir la maladie de décompression ?\nQuelles précautions avant une séance ?\nComment éviter l'intoxication à l'oxygène ?\nQuelles sont les recommandations post-traitement ?\nComment se préparer psychologiquement ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Oxygénation hyperbare", "description": "Quelles conditions traitent l'oxygénation hyperbare ?\nComment se déroule une séance d'oxygénation ?\nQuelle est la durée d'une séance ?\nY a-t-il des effets secondaires ?\nQui peut administrer ce traitement ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Oxygénation hyperbare", "description": "Quelles complications peuvent survenir ?\nComment gérer une embolie gazeuse ?\nQuels risques liés à l'oxygénation hyperbare ?\nComment prévenir les infections en chambre ?\nQuels signes d'une complication grave ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Oxygénation hyperbare", "description": "Quels sont les facteurs de risque de décompression ?\nQui est à risque d'intoxication à l'oxygène ?\nQuels antécédents augmentent les risques ?\nComment l'âge influence-t-il les risques ?\nQuels médicaments augmentent les risques ?", "url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=REM+Sleep+Behavior+Disorder&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une décompression ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de décompression se fait par l'évaluation des symptômes et des antécédents d'immersion." } }, { "@type": "Question", "name": "Quels tests pour l'oxygénation hyperbare ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie et des évaluations cliniques sont utilisés pour déterminer l'indication." } }, { "@type": "Question", "name": "Quels symptômes indiquent un traitement ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs articulaires, des troubles neurologiques ou des brûlures peuvent indiquer un traitement." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par l'amélioration des symptômes et des tests de suivi après traitement." } }, { "@type": "Question", "name": "Quels critères pour l'admission en chambre hyperbare ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent des conditions médicales spécifiques et l'absence de contre-indications." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'oxygénation hyperbare ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des douleurs, des vertiges, et des troubles de la vision." } }, { "@type": "Question", "name": "Comment se manifeste l'intoxication à l'oxygène ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication à l'oxygène se manifeste par des convulsions, des nausées et des troubles respiratoires." } }, { "@type": "Question", "name": "Quels signes d'une embolie gazeuse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs thoraciques, des difficultés respiratoires et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels symptômes après une séance d'oxygénation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Après une séance, des sensations de fatigue ou de légers maux de tête peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une réaction allergique peut se manifester par des éruptions cutanées, des démangeaisons ou un gonflement." } }, { "@type": "Question", "name": "Comment prévenir la maladie de décompression ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une ascension lente après la plongée et des pauses de sécurité." } }, { "@type": "Question", "name": "Quelles précautions avant une séance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de fumer, de consommer de l'alcool et informez le médecin de vos antécédents médicaux." } }, { "@type": "Question", "name": "Comment éviter l'intoxication à l'oxygène ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Pour éviter l'intoxication, respectez les protocoles de traitement et les durées recommandées." } }, { "@type": "Question", "name": "Quelles sont les recommandations post-traitement ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Après traitement, reposez-vous et évitez les activités physiques intenses pendant 24 heures." } }, { "@type": "Question", "name": "Comment se préparer psychologiquement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Préparez-vous en vous informant sur le traitement et en discutant avec des professionnels." } }, { "@type": "Question", "name": "Quelles conditions traitent l'oxygénation hyperbare ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle traite des conditions comme la maladie de décompression, les infections et les brûlures." } }, { "@type": "Question", "name": "Comment se déroule une séance d'oxygénation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Une séance se déroule dans une chambre pressurisée où le patient respire de l'oxygène pur." } }, { "@type": "Question", "name": "Quelle est la durée d'une séance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une séance dure généralement entre 60 et 120 minutes, selon la condition traitée." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des douleurs aux oreilles, des nausées ou des troubles visuels." } }, { "@type": "Question", "name": "Qui peut administrer ce traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement doit être administré par des professionnels de santé formés en médecine hyperbare." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions pulmonaires, des convulsions et des infections." } }, { "@type": "Question", "name": "Comment gérer une embolie gazeuse ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une embolie gazeuse nécessite une intervention rapide, souvent avec une oxygénation hyperbare." } }, { "@type": "Question", "name": "Quels risques liés à l'oxygénation hyperbare ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des barotraumatismes, des troubles de la vision et des réactions allergiques." } }, { "@type": "Question", "name": "Comment prévenir les infections en chambre ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Pour prévenir les infections, maintenez une bonne hygiène et suivez les protocoles de désinfection." } }, { "@type": "Question", "name": "Quels signes d'une complication grave ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques intenses ou des troubles neurologiques nécessitent une attention immédiate." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de décompression ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la profondeur de plongée, la durée et l'absence de pauses de sécurité." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication à l'oxygène ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les plongeurs et les patients recevant une oxygénation hyperbare à haute pression sont à risque." } }, { "@type": "Question", "name": "Quels antécédents augmentent les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de troubles respiratoires ou neurologiques peuvent augmenter les risques." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir un risque accru de complications en raison de la fragilité des tissus." } }, { "@type": "Question", "name": "Quels médicaments augmentent les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments, comme les diurétiques, peuvent augmenter le risque de déshydratation et de complications." } } ] } ] }

Sources (10000 au total)

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

NPC1 encodes a lysosomal protein involved in cholesterol transport. Biallelic mutations in this gene may lead to Niemann-Pick disease type C (NPC), a lysosomal storage disorder. The role of NPC1 in al...

Free-Water Imaging of the Nucleus Basalis of Meynert in Patients With Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.

Cognitive impairments are common in idiopathic REM sleep behavior disorder (iRBD), in which the cholinergic degeneration of nucleus basalis of Meynert (NBM) may play an important role. However, the pr... We compared the baseline free-water values in the NBM between 59 healthy controls (HCs), 57 patients with iRBD, 57 patients with Parkinson disease (PD) with normal cognition (PD-NC), and 64 patients w... IRBD, PD-NC, and PD-CI groups had significantly increased free-water values in the NBM compared with HCs, whereas PD-CI had higher free-water values compared with iRBD and PD-NC. In patients with iRBD... This study proves that free-water values in the NBM are elevated cross-sectionally and longitudinally and are associated with the progression of cognitive impairment and depression in patients with iR...

Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.

Many patients with Parkinson's disease suffer from REM sleep behavior disorder, potentially preceding the onset of motor symptoms. Phospho-alpha-synuclein is detectable in skin biopsies of patients wi... Patients with Parkinson's disease (n = 43) who had undergone skin biopsy for the immunohistochemical detection of phosphorylated alpha-synuclein were screened for REM sleep behavior disorder using RBD... Dermal alpha-synuclein deposition was more frequently found (81.8% vs. 52.4%, p = 0.05) and was more abundant (p = 0.01) in patients with Parkinson's disease suffering from probable REM sleep behavior... The phenotype of REM sleep behavior disorder is associated with high amounts of dermal alpha-synuclein deposition, demonstrating a strong involvement of peripheral nerves in patients with this non-mot...

Sleep and wakefulness disturbances in Parkinson's disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia.

Sleep disorders (SDs) are common non-motor symptoms of Parkinson's disease (PD) with wide variability in their prevalence rates. The etiology of SDs in PD is multifactorial because the degenerative pr...

Characterization of attentional event-related potential from REM sleep behavior disorder patients based on explainable machine learning.

Idiopathic rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of neurodegeneration and is associated with cortical dysfunction. The purpose of this study was to investigate the spa... An algorithm based on a convolutional neural network (CNN) was devised to discriminate cortical current source activities of iRBD patients due to single-trial event-related potentials (ERPs), from tho... The trained classifier yielded high classification accuracy. The critical features for the classification were determined by layer-wise relevance propagation, so that the spatiotemporal characteristic... These results suggest that the recognized dysfunction in visuospatial attention of iRBD patients originates from neural activity impairment in relevant cortical regions and may contribute to the devel...

Former participation in professional football as an occupation in patients with isolated REM sleep behavior disorder leading to a synucleinopathy: a case-control study.

Contact sports such as football are associated with late development of neurodegenerative diseases, in part due to the deleterious effect of repetitive head impacts during participation. Isolated REM ... To assess former participation in professional football as an occupation in IRBD.... In a case-control retrospective study, having played football as a professional occupation in the Spanish Football Professional Leagues was examined interviewing polysomnographically confirmed IRBD pa... Among 228 Caucasian Spanish IRBD patients with 68.5 ± 7.2 years, six (2.63%) were retired professional footballers. Length professional football career ranged between 11 and 16 years. Interval between... We found an overrepresentation of former professional footballers in IRBD patients who later developed PD and DLB after four decades from professional retirement. In professional footballers the devel...

Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease.

Mild cognitive impairment (MCI) is commonly present at the time of Parkinson's Disease (PD) diagnosis, but its prevalence amongst individuals at increased risk of PD is unclear.... Cognition was assessed using the Montreal Cognitive Assessment (MoCA) in 208 participants in the PREDICT-PD study, and 25 participants with REM-sleep behaviour disorder (RBD). Prevalence of MCI level ... Total MoCA scores were worse in the higher risk than the lower risk group defined as those below the 15th percentile of risk (p = 0.009), and in the RBD group compared to all healthy participants (p <... Cognitive impairment is increased in different groups at higher risk of PD, particularly in the subgroup formally diagnosed with RBD....